a Molecular Biophysics and Biophysical Chemistry Group, Interdisciplinary Biotechnology Unit , Aligarh Muslim University , Aligarh 202002 , India.
b Department of Pharmaceutical Chemistry , College of Pharmacy, King Saud University , P.O. Box 2457, Riyadh 11451 , Saudi Arabia.
J Biomol Struct Dyn. 2018 Apr;36(5):1261-1273. doi: 10.1080/07391102.2017.1318718. Epub 2017 Apr 27.
The aggregation phenomenon (amyloid and amorphous) is associated with several pathological complications in human, such as Alzheimer's, Parkinson's, Huntington, Cataract diseases, and Diabetes mellitus type 2. In the present study we are offering evidence and breaking the general belief with regard to the polyphenols action as protein aggregate inhibitors. Herein we confirm that tannic acid (TA) is not only an amyloid inducer, but also it switches one type of conformation, ultimately morphology, into another. We ascertain based on our findings that aggregates are not rigid structures and the stability can be challenged under certain conditions. This study also confirms that unfolded and amorphous aggregates can serve as precursors of amyloids and TA interactions with unordered aggregates (amorphous) bringing orderliness in the conformation via amyloidosis. The shifting of unordered conformation toward orderliness is governed by the modulation in surface hydrophobic patches in Concanavalin A (ConA). Hence, a degree of exposed hydrophobic cluster can be claimed as a strong parameter to detect and distinguish the native, amorphous and both types of amyloids. Turbidity and Rayleigh light scattering measurements followed similar pattern while Thioflavin T and 1-anilino-8-naphthalene sulfonate fluorescence assays of the binding with amorphous and amyloid followed an inverse relation. Electron microscopic studies revealed the morphological variation in the ConA at 65°C as amorphous while the ConA treated with TA followed by heat treatment at 65°C was defined as amyloid in nature. Interestingly for the first time we are reporting the slight agglutination activity by the ConA amyloids.
聚集现象(淀粉样和无定形)与人类的几种病理并发症有关,如阿尔茨海默病、帕金森病、亨廷顿病、白内障疾病和 2 型糖尿病。在本研究中,我们提供了证据,并打破了关于多酚作为蛋白质聚集抑制剂的作用的普遍看法。在这里,我们证实鞣酸(TA)不仅是一种淀粉样物诱导剂,而且它还将一种构象(最终是形态)转变为另一种构象。根据我们的发现,我们确定了聚集物不是刚性结构,在某些条件下稳定性可以受到挑战。这项研究还证实,无定形和无定形聚集物可以作为淀粉样物的前体,并且 TA 与无定形聚集物(无定形)相互作用通过淀粉样变性使构象有序。无定形构象向有序性的转变受伴刀豆球蛋白 A(ConA)表面疏水区的调制控制。因此,可以声称一定程度的暴露疏水区簇作为检测和区分天然、无定形和两种类型淀粉样物的强参数。浊度和瑞利光散射测量遵循类似的模式,而无定形和淀粉样物与 Thioflavin T 和 1-苯胺-8-萘磺酸荧光测定的结合则呈相反关系。电子显微镜研究表明,ConA 在 65°C 下呈现无定形形态,而用 TA 处理后再在 65°C 下热处理的 ConA 则被定义为天然淀粉样物。有趣的是,我们首次报道了 ConA 淀粉样物的轻微凝集活性。